← Back to patent-cliff list
布洛芬/盐酸苯海拉明
Tier C — Watch / tradeIbuprofen/Diphenhydramine Hydrochloride
辉瑞
Originator
2005
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：HRH1、COXs
Brand：Advil Pm
Indications (approved)：入睡和睡眠障碍、疼痛
Regional status
US
批准上市
2005-12-21
EU
-
China
批准上市
2026-02-10
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Ibuprofen/Diphenhydramine Hydrochloride?
Approved indications include: 入睡和睡眠障碍, 疼痛.
When does the Ibuprofen/Diphenhydramine Hydrochloride patent expire?
No public expiry year is available for Ibuprofen/Diphenhydramine Hydrochloride yet; this page updates once verified.
How do I get a quote for Ibuprofen/Diphenhydramine Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24